Sfoglia per Autore
Diagnostic problems in “clinically definite” multiple sclerosis patients with normal CSF and multiple MRI abnormalities
1994 Fieschi, Cesare; Gasperini, Claudio; Ristori, Giovanni; S., Bastianello; F., Girmenia; Leuzzi, Vincenzo; Buttinelli, Carla; Pozzilli, Carlo; Rasura, Maurizia
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.
1995 Gasperini, Claudio; Grasso, Mg; Fiorelli, Marco; Millefiorini, Enrico; Morino, S; Anzini, A; Colleluori, A; Salvetti, Marco; Buttinelli, Carla; Pozzilli, Carlo
Development of neutralizing antibodies in patients treated with IFN beta 1a
1997 Pozzilli, Carlo; G., Antonelli; F., Bagnato; E., Simeoni; S., Galgani; Gasperini, Claudio; T., Koudriatseva; Salvetti, Marco; Bastianello, Stefano; Fieschi, Cesare; Dianzani, Ferdinando
Magnetic resonance disease activity in multiple sclerosis (MS): correlation with menstrual cycle phase and hormonal parameters
1997 Martocchia, A.; Pozzilli, Carlo; Proietti, Antonella; Frontoni, Marco; Mainero, Carlo; D'Urso, Rosaria; Gasperini, Claudio; Falaschi, Paolo
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis.
1997 Colosimo, Carlo; Pozzilli, Carlo; Frontoni, Marco; D., Farina; T., Koudriavtseva; Gasperini, Claudio; Salvetti, Marco; Valesini, Guido
Relationship between menstrual cycle phase and clinical course in multiple sclerosis (ms)
1997 Martocchia, A.; Pozzilli, Carlo; Proietti, Antonella; Faroni, J.; Mainero, Carlo; D'Urso, Rosaria; Gasperini, Claudio; Falaschi, Paolo
determinant spreading without disease progression in multiple sclerosis
1998 Ristori, Giovanni; C., Montesperelli; Buttinelli, Carla; G., Borsellino; Gasperini, Claudio; Pozzilli, Carlo; A., Perna; Salvetti, Marco
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a
1998 Antonelli, Guido; Bagnato, F.; Pozzilli, Carlo; Simeoni, E.; Bastianelli, S.; Currenti, M.; De Pisa, F.; Fieschi, Cesare; Gasperini, C.; Salvetti, M.; Dianzani, F.
Serum amyloid a (SAA) protein in increased in the serum of patients with relapsing-remitting multiple sclerosis (MS)
1998 Ristori, Giovanni; F., Laurenti; P., Stacchini; Gasperini, Claudio; P., Fiori; C., Montesperelli; R., Bomprezzi; F., Bagnato; Buttinelli, Carla; Pozzilli, Carlo; Salvetti, Marco
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis
1998 Ristori, Giovanni; Laurenti, Francesco; Stacchini, P; Gasperini, Claudio; Buttinelli, Carla; Pozzilli, Carlo; Salvetti, Marco
Antinuclear antibodies and MRI activity in multiple sclerosis.
1998 Pozzilli, Carlo; Bastianello, Stefano; Gasperini, Claudio; Salvetti, Marco
Interleukin-12 mediated NKRP1A upregulation and consequent enhancement of endothelial transmigration of Vd2+ TCRgd+ T lymphocytes from healthy donors and multiple sclerosis
1999 Poggi, A; Zocchi, Mr; Costa, P; Ferrero, E; Borsellino, G; Placido, R; Galgani, S; Salvetti, Marco; Gasperini, Claudio; Ristori, Giovanni; BROSNAN CF AND BATTISTINI, L.
T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis.
1999 Ristori, Giovanni; Montesperelli, C; Gasperini, Claudio; Battistini, L; Borsellino, G; Buttinelli, Carla; Cannoni, S; Perna, A; Pozzilli, Carlo; Salvetti, Marco
Antinuclear antibody and response to IFNbeta-1a therapy in relasping-remitting multiple sclerosis
2000 Ciccarelli, O; Bagnato, F; Mainero, C; Salvetti, Marco; Paolillo, A; Gasperini, Claudio; Bastianello, S; Pozzilli, Carlo
Evidence for a role of gamma delta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens
2000 Borsellino, G; Koul, O; Placido, R; Tramonti, D; Luchetti, S; Galgani, S; Salvetti, Marco; Gasperini, Claudio; Ristori, Giovanni; Bonetti, B; Bach, S; Cipriani, B; Battistini, L.
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
2002 Gasperini, Claudio; Paolillo, A; Giugni, E; Galgani, S; Bagnato, F; Mainero, C; Onesti, Emanuela; Bastianello, S; Pozzilli, Carlo
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis.
2002 Pozzilli, Carlo; Antonini, Giovanni; Bagnato, F; Mainero, C; Tomassini, Valentina; Onesti, Emanuela; Fantozzi, R; Galgani, S; Pasqualetti, Patrizio; Millefiorini, Enrico; Spadaro, Maria; Dahlke, F; Gasperini, Claudio
Early relapses after the first dose of natalizumab in active multiple sclerosis patients
2008 D., Centonze; R., Furlan; Gasperini, Claudio; Salvetti, Marco; L., Battistini
New oral drugs for multiple sclerosis
2009 Gasperini, Claudio; Ruggieri, Serena
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets
2010 Pozzilli, Carlo; Gasperini, Claudio; Ruggieri, Serena
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Diagnostic problems in “clinically definite” multiple sclerosis patients with normal CSF and multiple MRI abnormalities | 1994 | Fieschi, Cesare; Gasperini, Claudio; Ristori, Giovanni; S., Bastianello; F., Girmenia; Leuzzi, Vincenzo; Buttinelli, Carla; Pozzilli, Carlo; Rasura, Maurizia | |
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. | 1995 | Gasperini, Claudio; Grasso, Mg; Fiorelli, Marco; Millefiorini, Enrico; Morino, S; Anzini, A; Colleluori, A; Salvetti, Marco; Buttinelli, Carla; Pozzilli, Carlo | |
Development of neutralizing antibodies in patients treated with IFN beta 1a | 1997 | Pozzilli, Carlo; G., Antonelli; F., Bagnato; E., Simeoni; S., Galgani; Gasperini, Claudio; T., Koudriatseva; Salvetti, Marco; Bastianello, Stefano; Fieschi, Cesare; Dianzani, Ferdinando | |
Magnetic resonance disease activity in multiple sclerosis (MS): correlation with menstrual cycle phase and hormonal parameters | 1997 | Martocchia, A.; Pozzilli, Carlo; Proietti, Antonella; Frontoni, Marco; Mainero, Carlo; D'Urso, Rosaria; Gasperini, Claudio; Falaschi, Paolo | |
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis. | 1997 | Colosimo, Carlo; Pozzilli, Carlo; Frontoni, Marco; D., Farina; T., Koudriavtseva; Gasperini, Claudio; Salvetti, Marco; Valesini, Guido | |
Relationship between menstrual cycle phase and clinical course in multiple sclerosis (ms) | 1997 | Martocchia, A.; Pozzilli, Carlo; Proietti, Antonella; Faroni, J.; Mainero, Carlo; D'Urso, Rosaria; Gasperini, Claudio; Falaschi, Paolo | |
determinant spreading without disease progression in multiple sclerosis | 1998 | Ristori, Giovanni; C., Montesperelli; Buttinelli, Carla; G., Borsellino; Gasperini, Claudio; Pozzilli, Carlo; A., Perna; Salvetti, Marco | |
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a | 1998 | Antonelli, Guido; Bagnato, F.; Pozzilli, Carlo; Simeoni, E.; Bastianelli, S.; Currenti, M.; De Pisa, F.; Fieschi, Cesare; Gasperini, C.; Salvetti, M.; Dianzani, F. | |
Serum amyloid a (SAA) protein in increased in the serum of patients with relapsing-remitting multiple sclerosis (MS) | 1998 | Ristori, Giovanni; F., Laurenti; P., Stacchini; Gasperini, Claudio; P., Fiori; C., Montesperelli; R., Bomprezzi; F., Bagnato; Buttinelli, Carla; Pozzilli, Carlo; Salvetti, Marco | |
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis | 1998 | Ristori, Giovanni; Laurenti, Francesco; Stacchini, P; Gasperini, Claudio; Buttinelli, Carla; Pozzilli, Carlo; Salvetti, Marco | |
Antinuclear antibodies and MRI activity in multiple sclerosis. | 1998 | Pozzilli, Carlo; Bastianello, Stefano; Gasperini, Claudio; Salvetti, Marco | |
Interleukin-12 mediated NKRP1A upregulation and consequent enhancement of endothelial transmigration of Vd2+ TCRgd+ T lymphocytes from healthy donors and multiple sclerosis | 1999 | Poggi, A; Zocchi, Mr; Costa, P; Ferrero, E; Borsellino, G; Placido, R; Galgani, S; Salvetti, Marco; Gasperini, Claudio; Ristori, Giovanni; BROSNAN CF AND BATTISTINI, L. | |
T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis. | 1999 | Ristori, Giovanni; Montesperelli, C; Gasperini, Claudio; Battistini, L; Borsellino, G; Buttinelli, Carla; Cannoni, S; Perna, A; Pozzilli, Carlo; Salvetti, Marco | |
Antinuclear antibody and response to IFNbeta-1a therapy in relasping-remitting multiple sclerosis | 2000 | Ciccarelli, O; Bagnato, F; Mainero, C; Salvetti, Marco; Paolillo, A; Gasperini, Claudio; Bastianello, S; Pozzilli, Carlo | |
Evidence for a role of gamma delta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens | 2000 | Borsellino, G; Koul, O; Placido, R; Tramonti, D; Luchetti, S; Galgani, S; Salvetti, Marco; Gasperini, Claudio; Ristori, Giovanni; Bonetti, B; Bach, S; Cipriani, B; Battistini, L. | |
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a. | 2002 | Gasperini, Claudio; Paolillo, A; Giugni, E; Galgani, S; Bagnato, F; Mainero, C; Onesti, Emanuela; Bastianello, S; Pozzilli, Carlo | |
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis. | 2002 | Pozzilli, Carlo; Antonini, Giovanni; Bagnato, F; Mainero, C; Tomassini, Valentina; Onesti, Emanuela; Fantozzi, R; Galgani, S; Pasqualetti, Patrizio; Millefiorini, Enrico; Spadaro, Maria; Dahlke, F; Gasperini, Claudio | |
Early relapses after the first dose of natalizumab in active multiple sclerosis patients | 2008 | D., Centonze; R., Furlan; Gasperini, Claudio; Salvetti, Marco; L., Battistini | |
New oral drugs for multiple sclerosis | 2009 | Gasperini, Claudio; Ruggieri, Serena | |
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets | 2010 | Pozzilli, Carlo; Gasperini, Claudio; Ruggieri, Serena |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile